Read this manager's filing book
Disclosed positions
TANAKA CAPITAL MANAGEMENT INC: source evidence dated 2026-05-19T03:59:59.999Z.
- Issuer
- United States Antimony
- Ticker
- UAMY
- Class
- COM
- Reported value
- $5,377,000
- Reported amount
- 615,975
- Unit
- SH
- Option
- None
The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.
What was reported for this quarter?
13F positions are dated quarter-end holdings, with later publication and possible amendments. Read report period and availability before calling them current.
SEC 13F-HR: 0000816788-26-000002Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filings
Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filingsKeep reporting dates and units beside the answer, and inspect its original citations.
Disclosed positions
See the complete disclosed positions
| United States Antimony | UAMY | COM | $5,377,000 | 615,975 | SH | None |
| NexGen Energy | NXE | COM | $5,095,000 | 439,205 | SH | None |
| Corcept Therapeutics | CORT | COM | $4,469,000 | 110,854 | SH | None |
| Nvidia | NVDA | COM | $4,322,000 | 24,780 | SH | None |
| Aura Minerals, Inc. | Unresolved | COM | $4,087,000 | 50,085 | SH | None |
| Nuvation Bio Inc. | NUVB | COM | $3,869,000 | 901,825 | SH | None |
| Apple Computing | AAPL | COM | $3,263,000 | 12,859 | SH | None |
| Intellia Therapeutics | IJR | COM | $2,822,000 | 220,107 | SH | None |
| Catalyst Pharmaceuticals | CPRX | COM | $2,808,000 | 113,418 | SH | None |
| Onto Innovation | ONTO | COM | $2,553,000 | 12,448 | SH | None |
| Applied Materials | AMAT | COM | $2,376,000 | 6,953 | SH | None |
| Cameco | CCJ | COM | $2,343,000 | 21,575 | SH | None |
| Symbotic | SYM | COM | $2,293,000 | 43,094 | SH | None |
| AFLAC Inc. | AFL | COM | $2,198,000 | 20,039 | SH | None |
| Electrovaya | ELVA | COM | $1,986,000 | 253,930 | SH | None |
| Stifel Financial Corp. | SF | COM | $1,411,000 | 19,090 | SH | None |
| The Carlyle Group | Unresolved | COM | $1,393,000 | 28,791 | SH | None |
| Amazon.com Inc. | AMZN | COM | $1,260,000 | 6,052 | SH | None |
| QUALCOMM | QCOM | COM | $1,172,000 | 9,104 | SH | None |
| PepsiCo, Inc. | PEP | COM | $1,102,000 | 7,095 | SH | None |
| Uranium Energy Corp. | UEC | COM | $1,039,000 | 77,051 | SH | None |
| Mastercard | MA | COM | $946,000 | 1,893 | SH | None |
| Philip Morris International | PM | COM | $471,000 | 2,851 | SH | None |
| Meta Platforms | META | COM | $459,000 | 803 | SH | None |
| ASML Holding N V ADR | Unresolved | COM | $296,000 | 224 | SH | None |
| Accenture plc | ACN | COM | $100,000 | 502 | SH | None |
| iShares Russell 1000 | IWB | COM | $84,000 | 235 | SH | None |
| iShares Russell 1000 Growth | IWF | COM | $64,000 | 149 | SH | None |
| JPMorgan Chase and Co. | JPM | COM | $55,000 | 188 | SH | None |
| BeyondSpring Inc | BYSI | COM | $43,000 | 26,296 | SH | None |
| iShares Russell 1000 Value | IWD | COM | $26,000 | 123 | SH | None |
| Colgate-Palmolive Co. | CL | COM | $22,000 | 263 | SH | None |
| iShares Core SP Small Cap | IJR | COM | $14,000 | 109 | SH | None |
| Mondelez International, Inc. | MDLZ | COM | $11,000 | 192 | SH | None |
| Bristol-Myers Squibb | BMY | COM | $10,000 | 166 | SH | None |
| iShares MSCI EAFE | EFA | COM | $10,000 | 103 | SH | None |
| iShares MSCI EAFE Growth | EFG | COM | $9,000 | 81 | SH | None |
| Procter And Gamble | PG | COM | $9,000 | 63 | SH | None |
| Intel Corp. | INTC | COM | $8,000 | 180 | SH | None |
| Kraft Heinz Company | Unresolved | COM | $6,000 | 279 | SH | None |
| Church and Dwight Co. Inc. | CHD | COM | $2,000 | 26 | SH | None |
| Johnson and Johnson | JNJ | COM | $2,000 | 9 | SH | None |
| Travelers Group | TRV | COM | $2,000 | 6 | SH | None |
No matching rows. Clear the filter to see all records.
Largest 50 positions by reported value; the filing may contain more positions.
How amendments affect these holdings
This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 4 positions lack a resolved ticker and 0 positions are put or call entries.
A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.
Quarter end and public filing date
Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.